6/11/2024
to
Houston
Advancing cancer immunotherapy through research, education, and collaboration.
Accelerate your design, make, test cycle with leading in vitro ADME & in vivo DMPK
This week (31 March 2025) marks two years since Concept Life Sciences came under Limerston Capital ownership.
Find out about our solid-phase peptide synthesis expertise.